Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2008 1
2009 3
2010 3
2011 1
2012 3
2013 4
2014 5
2015 2
2016 2
2017 6
2018 4
2019 6
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
New therapeutic strategies for malignant pleural mesothelioma.
Bonelli MA, Fumarola C, La Monica S, Alfieri R. Bonelli MA, et al. Among authors: fumarola c. Biochem Pharmacol. 2017 Jan 1;123:8-18. doi: 10.1016/j.bcp.2016.07.012. Epub 2016 Jul 16. Biochem Pharmacol. 2017. PMID: 27431778 Review.
Immunotherapeutic Approaches in Malignant Pleural Mesothelioma.
Terenziani R, Zoppi S, Fumarola C, Alfieri R, Bonelli M. Terenziani R, et al. Among authors: fumarola c. Cancers (Basel). 2021 Jun 4;13(11):2793. doi: 10.3390/cancers13112793. Cancers (Basel). 2021. PMID: 34199722 Free PMC article. Review.
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines.
Digiacomo G, Fumarola C, La Monica S, Bonelli MA, Cretella D, Alfieri R, Cavazzoni A, Galetti M, Bertolini P, Missale G, Petronini PG. Digiacomo G, et al. Among authors: fumarola c. Front Oncol. 2020 Sep 23;10:563249. doi: 10.3389/fonc.2020.563249. eCollection 2020. Front Oncol. 2020. PMID: 33072590 Free PMC article.
Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer.
Cavazzoni A, Digiacomo G, Alfieri R, La Monica S, Fumarola C, Galetti M, Bonelli M, Cretella D, Barili V, Zecca A, Giovannetti E, Fiorentino M, Tiseo M, Petronini PG, Ardizzoni A. Cavazzoni A, et al. Among authors: fumarola c. Cancers (Basel). 2020 Mar 12;12(3):666. doi: 10.3390/cancers12030666. Cancers (Basel). 2020. PMID: 32178474 Free PMC article.
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.
Castelli R, Bozza N, Cavazzoni A, Bonelli M, Vacondio F, Ferlenghi F, Callegari D, Silva C, Rivara S, Lodola A, Digiacomo G, Fumarola C, Alfieri R, Petronini PG, Mor M. Castelli R, et al. Among authors: fumarola c. Eur J Med Chem. 2019 Jan 15;162:507-524. doi: 10.1016/j.ejmech.2018.11.029. Epub 2018 Nov 13. Eur J Med Chem. 2019. PMID: 30472599
44 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page